Literature DB >> 1444232

Non-toxic sensitization of cancer chemotherapy by combined vitamin C and K3 pretreatment in a mouse tumor resistant to oncovin.

H S Taper1, M Roberfroid.   

Abstract

The effects of combined vitamin C and K3 i.p. injected 3 hours before i.p. administration of single dose of oncovin, to which the ascites liver tumor in mouse (T.L.T.) was completely resistant, were investigated. This pretreatment sensitized the tumor resistant to oncovin, whereas a separate pretreatment with vitamin C or K3 alone was without any effect. This tumor sensitization to the chemotherapy was completely suppressed by catalase pretreatment, thus indicating that hydrogen peroxide generation with subsequent oxidative stress and its consequences may be involved here. Since this sensitization was without any increased general and organ toxicity, its possible introduction into classical protocols of human cancer treatment would be without any supplementary risk.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444232

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  alpha-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate.

Authors:  M Tomasetti; E Strafella; S Staffolani; L Santarelli; J Neuzil; R Guerrieri
Journal:  Br J Cancer       Date:  2010-03-23       Impact factor: 7.640

2.  Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.

Authors:  Rumiana Bakalova; Severina Semkova; Donika Ivanova; Zhivko Zhelev; Thomas Miller; Tsuguhide Takeshima; Sayaka Shibata; Dessislava Lazarova; Ichio Aoki; Tatsuya Higashi
Journal:  Oxid Med Cell Longev       Date:  2020-11-02       Impact factor: 6.543

3.  Targeting Glioblastoma via Selective Alteration of Mitochondrial Redox State.

Authors:  Akira Sumiyoshi; Sayaka Shibata; Zhivko Zhelev; Thomas Miller; Dessislava Lazarova; Ichio Aoki; Takayuki Obata; Tatsuya Higashi; Rumiana Bakalova
Journal:  Cancers (Basel)       Date:  2022-01-19       Impact factor: 6.639

4.  2-Bromo-1,4-naphthoquinone: a potentially improved substitute of menadione in Apatone™ therapy.

Authors:  F S Graciani; V F Ximenes
Journal:  Braz J Med Biol Res       Date:  2012-05-17       Impact factor: 2.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.